Session: Surveillance, Acquisition, and Prevention of <i>Clostridium difficile</i> (21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (April 1-4, 2011))

Sunday, April 3, 2011: 10:30 AM-12:30 PM

Chantilly Ballroom - EAST (Hilton Anatole)

CME Credits: 2

CPE Credits: 2.00

ACPE UPN: 0072-9999-11-006-L04-P (knowledge-based)

Type: Symposia

Summary: Clostridium difficile infection (CDI) remains a difficult HAI to track and prevent because of different surveillance methods, diagnostic performance and utilization, and an incomplete understanding of all sources of transmission. Subject experts will provide an overview of how CDI surveillance and diagnosis method impact CDI incidence, potential underappreciated sources of C. difficile transmission, and the impact large scale prevention efforts have had on CDI incidence.

Learning Objectives:

Compare the impact different surveillance methodologies and methods to diagnosing CDI can have on CDI incidence
Identify potential sources of C. difficile acquisition in healthcare facilities and in the community
Define the implementation and impact of a large scale CDI prevention project

Endorsed by:

Center for Disease Control and Prevention
Society of Infectious Diseases Pharmacists

Moderators:

Stuart Johnson, MD and L. Clifford McDonald, MD, FACP, FSHEA

10:30 AM

390

What's in a Name? Does Which We Call Clostridium difficile Infection by any other Name Smell as Sweet?
Erik R. Dubberke, MD, MSPH, Washington University School of Medicine

11:00 AM

391

You Are What You Eat: Clostridium difficile and You
Curtis J. Donskey, MD, Louis Stokes Cleveland Veterans Affairs Medical Center

11:30 AM

392

Large Scale Collaborative to Prevent C. difficile Infections: Successes and Challenges
Julie E. Mangino, MD, The Ohio State University Medical Center

62 Surveillance, Acquisition, and Prevention of Clostridium difficile